本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

爵士制药

109.92
+0.48000.44%
成交量:77.47万
成交额:8,511.13万
市值:66.51亿
市盈率:14.63
高:110.69
开:109.62
低:108.88
收:109.44
数据加载中...
2024/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/31

重要事件披露

Form 8-K - Current report
2024/07/26

重要事件披露

Form 8-K - Current report
2024/07/22

重要事件披露

Form 8-K - Current report
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/01

重要事件披露

Form 8-K - Current report
2024/04/26

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]